Japan Clears First iPSC Therapies for Clinical Use
March 25, 2026
Two iPSC-derived cell therapies receive time-limited authorization following early clinical trials
2 min read
False
Advertisement
Regulation & Standards
Repurposed Drugs Reshape Pricing Debate
March 19, 2026
Study models sustainable pricing for repurposed bevacizumab
2 min read
Building Quality into Advanced Therapies from Day One
March 13, 2026
Why early, risk-based thinking is critical in cell and gene therapy development
5 min read
What Does Corporate Compliance Really Mean?
By Stephanie Vine
March 10, 2026
Corporate compliance isn’t just about avoiding fines; it’s an opportunity to shape culture, partnerships, and everyday decision-making
10 min read
MHRA Approval for First UK-made mRNA Vaccine
February 27, 2026
Moderna receives MHRA approval for updated COVID-19 vaccine targeting SARS-CoV-2 variant LP.8.1
1 min read
Closing the Genomic Gap in Rare Disease
February 27, 2026
Ahead of Rare Disease Day, leaders from iHope and PacBio explore how technology, collaboration, and policy reform can bring accurate genomic diagnosis
6 min read
Quality Without Complexity: Interviewing Dipesh Patel
February 4, 2026
“Giving people enough space and a safe environment to do their job and innovate is fulfilling for them, and they will then, inevitably, develop solutions to the most pressing needs.”
4 min read
Why Soft Skills are More Important than Ever in Life Sciences
By Ivan Wall
February 3, 2026
We should not only find highly qualified scientists and engineers, but also ensure they are ready to work in a collaborative, respectful, and trusting environment
6 min read
Beating Biopharma Manufacturing Bottlenecks with Raman Spectroscopy
By Michelle Sestak
January 26, 2026
A look at the potential of Raman spectroscopy in biopharma – and what else lies on the horizon for this important technique
4 min read
Rebuilding Confidence in UK Pharma Manufacturing
By Martyn Williams
December 11, 2025
The UK’s pharma manufacturing base still has potential, but only if companies modernize operations, boost efficiency, and show global investors that the UK can compete on cost and capability.
6 min read
